Good

Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study

NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutr
Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment2

  • Top
  • Latest
  • seb59
    ·2021-03-09
    Good
    Reply
    Report
  • JavierLee
    ·2021-03-09
    good
    Reply
    Report